MENU

Click here to

×

Are you sure ?

Yes, do it No, cancel

Experimental Validation of the Enhancement of Biological Effects Using Enhanced-LET Proton Therapy

D Ma*, M Kerr , L Bronk , X Wang , N Sahoo , D Grosshans , R Mohan , F Guan , UT MD Anderson Cancer Center, Houston, TX

Presentations

(Tuesday, 7/16/2019) 1:15 PM - 1:45 PM

Room: Exhibit Hall | Forum 4

Purpose: To experimentally validate the hypothesis that increasing the intensity of low-energy protons with high linear energy transfer (LET) in target tumors can enhance the biological effects therein.

Methods: The depth dose and dose-averaged LET (LETd) in a water phantom for scanned proton beams have been pre-calculated using Geant4. An in-house Python code was used to perform physical dose optimizations to generate desired dose profiles and resultant LETd. A flat and a downslope spread-out Bragg peak (SOBP) dose distributions within a 4-cm wide target (5.8–9.8 cm) were generated separately. Two opposed flat or downslope fields were then used to generate a uniform target dose distribution. Using downslope fields can enhance the target LETd values due to the increased intensity of low-energy protons. The high-throughput method was adopted to spatially map the biological effects by employing a custom multi-step irradiation jig and 96-well plates. The middle eight columns of a 96-well plate were placed within the uniform dose region. The clonogenic survival was selected as the biological endpoint. The lung cancer H460 cells were irradiated. The Cs-137 photon source was used as the reference radiation.

Results: For proton irradiations, the cell surviving fractions for the middle six columns of the 96-well plates were averaged. At 2 Gy, the mean surviving fraction is 0.61±0.01, 0.50±0.02 and 0.45±0.02 using photons, opposed flat proton fields (LETd = 3.0 keV/μm), and opposed downslope proton fields (LETd = 4.6 keV/μm). At 4 Gy, the mean cell surviving fraction is 0.16±0.01, 0.14±0.01, and 0.08±0.01, respectively.

Conclusion: Two opposed downslope dose fields are more biologically effective in the target tumor in spite of the increased out-of-target dose. This beam delivery strategy has the potential for LET escalation in clinical practice, e.g., treatment for prostate cancer patients where parallel opposed fields are typically used.

Keywords

Not Applicable / None Entered.

Taxonomy

Not Applicable / None Entered.

Contact Email